SCHEMBL4732472

SCHEMBL4732472

Fc1ccc(-c2ccc(NC3CCN(c4ncccn4)CC3)c(Cl)c2)c(F)c1

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.47
PKM P14618 1/20 0.47
KDM4E B2RXH2 2/20 0.42
CNR1 P21554 2/20 0.42
CNR2 P34972 2/20 0.42
MALT1 Q9UDY8 1/20 0.41
SCD O00767 2/20 0.41
DPP4 P27487 1/20 0.41
DPP8 Q6V1X1 1/20 0.41
DPP9 Q86TI2 1/20 0.41
DPP7 Q9UHL4 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
MAPT P10636 1/20 0.40
GRM2 Q14416 3/20 0.38
SLC6A7 Q99884 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4732475 0.90 ALDH1A1 (0.52) ALDH1A1PKMKDM4ESCDDPP4
SCHEMBL4731711 0.88 ALDH1A1 (0.47) ALDH1A1PKMKDM4ESCDDPP4
SCHEMBL4729603 0.86 SCD (0.51) ALDH1A1PKMKDM4ESCDDPP4
SCHEMBL4730640 0.85 ALDH1A1 (0.44) ALDH1A1PKMKDM4ECNR1CNR2
SCHEMBL4731167 0.84 KDM4E (0.46) ALDH1A1PKMKDM4EMALT1DPP4
SCHEMBL4732131 0.82 ALDH1A1 (0.46) ALDH1A1PKMKDM4ECNR1CNR2
SCHEMBL4729025 0.81 MALT1 (0.50) ALDH1A1PKMKDM4ECNR1CNR2
SCHEMBL4732906 0.79 SLC6A7 (0.53) KDM4ECNR1CNR2MALT1MEN1
SCHEMBL4733745 0.79 KDM4E (0.48) ALDH1A1PKMKDM4EMALT1DPP4
SCHEMBL5090496 0.79 MALT1 (0.45) ALDH1A1PKMKDM4ECNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080139598-A1 Amine-linked Multicyclic Compounds and Methods of Their Use LEXICON PHARMACEUTICALS, INC. 2008-06-12 US claimed
WO-2008058064-A1 AMINE-LINKED MULTICYCLIC COMPOUNDS AS INHIBITORS OF THE PROLINE TRANSPORTER LEXICON PHARMACEUTICALS, INC. (US) 2008-05-15 WO claimed
US-20080139598-A1 Amine-linked Multicyclic Compounds and Methods of Their Use LEXICON PHARMACEUTICALS, INC. 2008-06-12 US disclosed
WO-2008058064-A1 AMINE-LINKED MULTICYCLIC COMPOUNDS AS INHIBITORS OF THE PROLINE TRANSPORTER LEXICON PHARMACEUTICALS, INC. (US) 2008-05-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080139598-A1 Amine-linked Multicyclic Compounds and Methods of Their Use MAOB, HNMT, MAOA ALDH1A1 287/4885PKM 1033/4885KDM4E 2225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.